ArticleThe Journal of clinical investigation2021

CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins.

Masami Shimizu-Albergine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.